Glenmark Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 20 Sep 23 | Sell₹1,704,000 | Praveen Kurkal | Individual | 2,000 | ₹852.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| State or Government | 358,820 | 0.127% |
| Individual Insiders | 10,685,508 | 3.79% |
| General Public | 42,611,942 | 15.1% |
| Institutions | 95,539,950 | 33.9% |
| Private Companies | 132,991,936 | 47.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 128,241,936 | ₹135.6b | 0% | no data | |||
| 13,666,546 | ₹14.4b | 0% | 0.01% | |||
| 8,597,867 | ₹9.1b | 0% | 2.45% | |||
| 7,315,751 | ₹7.7b | 6.82% | 0.47% | |||
| 7,200,000 | ₹7.6b | 0% | no data | |||
| 6,759,068 | ₹7.1b | 8.58% | 0.18% | |||
| 6,752,756 | ₹7.1b | 0% | 0.05% | |||
| 6,364,694 | ₹6.7b | 0% | 0.01% | |||
| 5,857,777 | ₹6.2b | 0.02% | no data | |||
| 4,750,000 | ₹5.0b | 0% | no data | |||
| 4,422,978 | ₹4.7b | 0% | 0.03% | |||
| 4,378,118 | ₹4.6b | -0.13% | 0.01% | |||
| 4,125,000 | ₹4.4b | 0% | 33.71% | |||
| 3,498,766 | ₹3.7b | 125% | 0.07% | |||
| 2,914,925 | ₹3.1b | -11.8% | 0.95% | |||
| 2,908,780 | ₹3.1b | 3.66% | no data | |||
| 2,321,691 | ₹2.5b | 895% | 0.1% | |||
| 1,506,327 | ₹1.6b | 55.1% | 0.01% | |||
| 1,285,292 | ₹1.4b | 13.9% | 0.02% | |||
| 1,180,058 | ₹1.2b | 140% | 0.04% | |||
| 1,175,263 | ₹1.2b | -18.5% | 0.05% | |||
| 1,171,911 | ₹1.2b | 136% | 0.26% | |||
| 1,167,988 | ₹1.2b | 0% | 0.02% | |||
| 1,110,327 | ₹1.2b | 0% | no data | |||
| 983,439 | ₹1.0b | 0% | no data |